JB

Joyshri Biswas

Active Director Director DIN 09507307
DIN 09507307 First appointment Feb 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value •••• Premium profile

About Joyshri Biswas

Data last updated:

Joyshri Biswas is a Director at Gi Care Life Sciences Private Limited (since 2022). The company operates in Trading. Gi Care Life Sciences Private Limited reported revenue of ₹1.27 Cr (FY 2025).

DIN 09507307
Primary Designation Director
Industry Trading
First Appointment 16 Feb 2022
Oldest Company Age 4 yrs
Largest company Gi Care Life Sciences Private Limited · ₹1.27 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Feb 20222022₹1.27 Cr (FY 2025)Active

Board colleagues of Joyshri Biswas

Directorship timeline

Open interactive timeline →
Gi Care Life Sciences Private Limited
Premium access

Shareholding and investment profile for Joyshri Biswas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Joyshri Biswas

Joyshri Biswas currently holds 1 directorship: Gi Care Life Sciences Private Limited (Director, since 16 Feb 2022, revenue ₹1.27 Cr (FY 2025)).

Joyshri Biswas was first appointed on 16 Feb 2022 as Director at Gi Care Life Sciences Private Limited.

The current boards of Joyshri Biswas's companies include Arindam Biswas (Gi Care Life Sciences Private Limited), Gourav Sharma (Gi Care Life Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available